| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.2M | -79.9% |
| R&D Expense | $24.0M | -47.5% |
| SG&A Expense | $38.0M | -48.1% |
| Operating Income | -$61.8M | +47.6% |
| Interest Expense | $11.0M | -13.0% |
| Pre-tax Income | -$49.3M | +72.4% |
| Income Tax | -$420K | -252.9% |
| Net Income | -$38.2M | +84.6% |
| EPS (Basic) | -$5.00 | +92.2% |
| EPS (Diluted) | -$5.00 | +92.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.5M | -65.5% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $38.1M | -61.3% |
| Total Assets | $53.5M | -50.8% |
| Current Liabilities | $23.3M | -62.2% |
| Total Liabilities | $155.8M | -19.6% |
| Stockholders' Equity | -$102.3M | -20.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.4M | +61.5% |
| Capital Expenditures | $792K | -7.4% |
| Investing Cash Flow | -$792K | +36.2% |
| Financing Cash Flow | $7.3M | -95.6% |
| Free Cash Flow | -$65.2M | +61.3% |